Amprius Technologies, INC Form 4 insider transactions
NYSE
Jonathan Bornstein, President of Amprius Lab, reports stock option grants and a pro rata distribution of shares following Amprius, Inc.'s dissolution.
NYSE
Constantin Ionel Stefan, Chief Technology Officer of Amprius Technologies, reports the assumption of stock options and a pro rata distribution of shares following Amprius, Inc.'s dissolution.
NYSE
Amprius Technologies CEO, Kang Sun, receives stock options as a result of Amprius, Inc.'s liquidation and distribution of shares.
NYSE
Director Steven Chu reports the assumption of stock options following the liquidation and dissolution of Amprius, Inc. and distribution of shares of Amprius Technologies, Inc.
NYSE
A significant shareholder of Amprius Technologies, Inc. liquidated and distributed its holdings, involving a contribution of shares and a pro rata distribution to its stockholders.
NYSE
Director Justin Mirro reported the sale of Amprius Technologies (AMPX) common stock in a series of transactions between September 3rd and September 5th, 2024.
NYSE
A reporting person at Amprius Inc. sold common stock in two transactions on September 3rd and 4th, 2024.
NYSE
Sandra Wallach, CFO of Amprius Technologies, sold 17,606 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Jonathan Bornstein, President of Amprius Lab, sold 18,644 shares of Amprius Technologies common stock to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Amprius Technologies CEO Kang Sun sold 33,333 shares of common stock on August 21, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
NYSE
Constantin Ionel Stefan, Chief Technology Officer of Amprius Technologies, sold 8,800 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Director Livingston Satterthwaite reports acquiring 283,019 shares of Amprius Technologies common stock and disposing of 291,639 shares.
NYSE
Director Justin Mirro reports acquisition and disposal of Amprius Technologies securities following an exchange of private warrants for common stock.
NYSE
Director Justin Mirro reports selling shares of Amprius Technologies (AMPX) in a series of transactions between June 12 and June 14, 2024.
NYSE
Form 4: Amprius Technologies Director Wen Hsieh Reports Acquisition of 125,000 Restricted Stock Units
Director Wen Hsieh reports acquiring 125,000 restricted stock units in Amprius Technologies, Inc.
NYSE
Director Kathleen A. Bayless reports acquiring 125,000 shares of Amprius Technologies common stock through restricted stock units.
NYSE
Director Steven Chu reports acquiring 125,000 shares of Amprius Technologies common stock through restricted stock units.
NYSE
Form 4: Amprius Technologies Director, Mary Gustanski, Reports Acquisition and Disposal of Common Stock
Director Mary Gustanski reported acquiring 114,583 shares of Amprius Technologies common stock in the form of restricted stock units and disposing of 146,396 shares.
NYSE
Form 4: Justin Mirro, Amprius Technologies Director, Reports Acquisition of 125,000 Restricted Stock Units
Director Justin Mirro reports acquisition of 125,000 restricted stock units in Amprius Technologies, Inc.
NYSE
Director Donald R. Dixon reports acquiring 125,000 shares of Amprius Technologies, Inc. common stock through restricted stock units.
NYSE
Constantin Ionel Stefan, Chief Technology Officer of Amprius Technologies, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Kang Sun, an officer at Amprius Technologies, sold shares of common stock on May 21 and 22, 2024, to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Jonathan Bornstein, President of Amprius Lab, sold shares of Amprius Technologies common stock to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Sandra Wallach, CFO of Amprius Technologies, sold shares of common stock on May 21 and May 22, 2024, to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Jonathan Bornstein, President of Amprius Lab, exercised stock options to acquire 1,007,867 shares of Amprius Technologies common stock at $0.05 per share.
NYSE
Jonathan Bornstein, President of Amprius Lab, exercised stock options and sold shares of Amprius Technologies under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Constantin Ionel Stefan, Chief Technology Officer of Amprius Technologies, reports acquisition and disposal of common stock and restricted stock units.
NYSE
Jonathan Bornstein, President of Amprius Lab, acquired 558,930 restricted stock units in Amprius Technologies, Inc.
NYSE
Sandra Wallach, CFO of Amprius Technologies, acquired 749,700 restricted stock units on March 19, 2024, according to a recent SEC filing.
NYSE
Director Kang Sun reports acquisition of 1,419,670 restricted stock units in Amprius Technologies, Inc.